No, Copeptin and Antidiuretic Hormone (ADH/AVP) Tests Are Not the Same
Copeptin is not the same as ADH (arginine vasopressin/AVP), but copeptin measurement serves as a stable, clinically superior surrogate marker for ADH levels because both are released in equimolar amounts from the same precursor molecule. 1
Key Differences Between the Two Tests
What They Measure
- ADH/AVP test: Directly measures the unstable antidiuretic hormone itself
- Copeptin test: Measures the C-terminal segment (CT-proAVP) of the AVP precursor peptide
Why Copeptin Has Replaced Direct ADH Measurement
The 2025 international expert consensus strongly recommends measuring plasma copeptin as a suitable alternative to direct AVP measurement in adults 1. The reasoning is straightforward:
Technical advantages of copeptin:
- Stability: Copeptin remains stable in blood samples, while AVP degrades rapidly
- Ease of measurement: Simple sandwich immunoassay vs. cumbersome radioimmunoassay for AVP
- Reliability: Strong correlation with AVP levels (correlation coefficient 0.62, p<0.001) 2
- Clinical availability: Copeptin assays are automated and readily available; AVP measurement is not routinely available in clinical practice 3, 4
The Biological Relationship
Copeptin and AVP are cleaved from the same precursor molecule and released in a 1:1 equimolar ratio from the posterior pituitary in response to identical stimuli (osmotic changes, hemodynamic stress) 1, 3, 4. This equimolar secretion makes copeptin an accurate reflection of AVP activity.
Clinical Application
When to Use Copeptin Testing
For diagnosing nephrogenic diabetes insipidus (NDI):
- Baseline copeptin >21.4 pmol/L is diagnostic for NDI in adults 1
- No additional testing needed at this threshold
For differentiating central DI from primary polydipsia:
- Stimulated copeptin <4.9 pmol/L after hypertonic saline infusion indicates central DI 5
- This approach is superior to the traditional water deprivation test
For SIADH diagnosis:
- Copeptin has limited utility due to wide overlap in hyponatremic patients 5
- However, copeptin >8.0 pmol/L correlates with SIADH diagnosis in pediatric patients when combined with Schwartz-Bartter criteria 6
Important Caveats
- Pediatric data is limited: Only a few reports have evaluated copeptin's diagnostic value in pediatric polyuric disorders 1
- Context matters: Acute illness and stress can cause nonspecific copeptin elevations, complicating interpretation in hyponatremia 5
- Not interchangeable for all purposes: While copeptin reflects AVP secretion, the exact physiological function of copeptin itself remains undetermined 7
Bottom line: In modern clinical practice, copeptin testing has effectively replaced direct AVP measurement for diagnosing disorders of water balance due to its superior stability, accessibility, and diagnostic accuracy 3, 4.